This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
There are numerous facets on employer-sponsored health care to explore in the KFF report’s 220 pages, but I’m going to focus in on a few issues with which I’m working these days: on prescriptiondrugs, telehealth, and mental health. In 2024, the average patient share amounts are shown in Figure 9.6
This latter point was emphasized in the survey noting that 71% of Americans said that drugprices were too high; 78% of people agreed that the government should be permitted to negotiate/regulate prescriptiondrugprices.
President Biden’s first few days on the job gave us a very clear view on how he sees conquering COVID: through a whole-of-government approach to public policies that bolster directly addressing the virus, along with the many forces shaping how we got here and how to come out of the pandemic era stronger. ” The plotline goes….
The authors note that “consumer-driven” health care is, “associated with neoliberal efforts to emphasize market factors in health reform,” de-emphasizing government regulation and financing. This concept can be potentially harmful, they believe, assuming that health care is a traditional market.
Having the Federal government paying for testing, tracking, and treatment for COVID-19. Women, being Chief Health Officers of their Families, influencing 80% of health care decisions, well know how to connect the dots between health care costs and their household financial wellness.
Another unifying health care issue is prescriptiondrugprices, which KFF has tracked for several years. Most voters across party have told previous KFF polls they believe in more government regulation or intervention on drug costs. Health Populi’s Hot Points: What most U.S.
This is what happened to pharma stock prices on Friday after President Trump and Secretary of Health and Human Services Alex Azar outlined their new policies focusing on prescriptiondrugprices. Seniors and government programs over-paying for drugs. The graph is the Nasdaq U.S.
And there’s very little bidding on drugs.” ” Remember that prescriptiondrug spending continues to hover around one-tenth of overall U.S. A move to re-align prescriptiondrugprices will be welcomed across the political spectrum as Big Pharma continues to take the bulk of the blame for rising healthcare costs.
While we have a divided government via split legislature, one winner in the 2018 midterm outcome is Medicaid. Another healthcare issue that should get traction in this legislative environment is prescriptiondrugpricing. “We want to give President Trump what he said he wanted in the campaign,” Rep.
Sanders, noting his call for big new government benefits like universal health care through Medicare for All and free college tuition. Senator Harris, too, mentioned government benefits like free college and Medicare for All as her health plan preference. ” Lower my drugprices. Lester Holt began with Sen.
consumer dissatisfaction with drugprices — across political party identification. insured consumers’ perspectives on prescriptiondrugpricing and the role of PBMs (pharmacy benefit managers). 9 in 10 insured Americans felt that prescriptions are more expensive in the U.S.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content